HMGB1 and cerebral small vessel disease: Figure 3 reveals recent discoveries in the pathogenesis of PSE, including elevated interleukin-6 (IL-6) plasma concentration, immunological markers (epinephrine and high-mobility group protein B1), and low serum neuropeptide Y levels, elevated theta oscillations within the hippocampus, and cerebral small vessel disease.